⏰ TL;DR (Too Long; Didn't Read)

☝

Cubelabs 3D prints ultra-precise, customized, and reinforced pure-titanium bone replacements

💡The Idea

Bone loss may occur in patients due to cancer, infection, or trauma
Off-the-shelf bone implants are often inadequate when facing complex medical cases, specifically in highly intricate bone structures such as ankles, jaws, and the chest
Cubelabs creates replacement bones for implant with reinforced pure titanium with improved biocompatibility and mechanical properties
Cubelabs’ employs ultra-precise, ISO-certified, 3D printing for highly personalized, ergonomic designs

Personalized fit and function - each implant is customized the patient's unique anatomy, matches the natural curvature and structure of the original bone, and enables optimal restoration of normal appearance and function
Advanced material properties - reduced number of side effects, higher elongation, and lower elastic ratio than with implants made from titanium alloys, while maintaining an implant strength that is comparable to the original bone
Innovative design features - for better integration with existing bone, reduced weight and increased strength, and optimized strength and flexibility
Improved surgical outcomes - more precise implant placement, shorter operation time, and improved accuracy
Enhanced patient quality of life - clinical studies show significant improvements in pain reduction, recuperation time, and functional outcomes
Biologically adaptive versatility - applicable to various medical conditions (cancer, infection, congenital deformities) with a porous design that promotes bone integration, reducing issues like bone deformation and density loss while adapting to diverse patient needs

Current business model - on-demand manufacturing with per implant pricing, performed through hospital procurement centers
Planned - Establish in-hospital printing centers as a service

The global Bone Implant Market size was valued at $4.54 billion in 2023 and is expected to grow to $9.82 billion by 2032 (source)
Additional market research reports estimate the global 3D printed orthopedic implants market size was $1.7 billion in 2021 with an expected growth of 16.2% annually to generate $7.76 billion by 2031 (source)

Korean clinical trials are underway
KO Medical Device Act in progress. Talus and chest implants in process of being approved by MFDS(Ministry of Food and Drug Safety)
EU MDR 2017/745 in progress. Expected to be attained by July 2024
UK MDR 2002 in progress. Expected to be attained by August 2024
In the US, the strategy of setting up internal hospital printing centers, will enable gaining immediate FDA approval on a per-center basis